Pharmaceutical Portfolio Management: Integrated decision-making in marketing and R&D,

This is a strategic management report that presents a comprehensive overview of effective portfolio management processes, with a focus on better preparing senior management, R&D and marketing executives for integrated decision-making across the organization as a whole. Use this report to improve product lifecycle decisions and ensure the right people are involved in making the right decisions, at the right time.

June Promotion – SAVE £745/€1199/$1199

Purchase the ‘Pharmaceutical Portfolio Management’ report before Friday 11th June 2004, and receive a FREE report of your choice from the list below:

Choose your free report from the list below:

• The Pharmacoeconomics Outlook

• The Pharmaceutical Sales Force Outlook

• Pharmaceutical Regulatory Affairs Outlook

• The Pharmaceutical Industry Paradox

• Pharmaceutical Strategic Alliances

• The Top 12 Pharmaceutical Companies

• The Women’s Health Outloook to 2008

• The Cancer Outlook to 2008

• The Cardiovascular Outlook to 2008

• The CNS Outlook to 2008

• The Antivirals Outlook to 2007

• The DTC Marketing Outlook 2003

• The Biotech Sector in the Post-Genomic Era

• New Cancer Therapeutics

• Pharmaceutical R&D Outsourcing Strategies

• The Lifestyle Drugs Outlook to 2007

• Next Generation Drugs

• Opportunities in R&D

Reuters Business Insight reports are published by Datamonitor, in association with Reuters. Reuters, the sphere logo and Reuters Business Insight are trade marks of the Reuters group of companies around the world and are used by Datamonitor under licence from Reuters.

To order email peter.barfoot@bioportfolio.com or purchase online at:

http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_2003.html#a153